Phar­ma brands spent $3.9B on TV ads in 2021, led by Sanofi, Re­gen­eron’s Dupix­ent and No­vo Nordisk’s Ry­bel­sus

Third-place is un­fa­mil­iar ter­ri­to­ry for Ab­b­Vie’s block­buster drug Hu­mi­ra – even when it comes to TV ad spend­ing. But that’s where the drug end­ed up in 2021 af­ter Ab­b­Vie switched up Hu­mi­ra’s typ­i­cal­ly top-spend bud­get and re­al­lo­cat­ed some of its spend­ing to new­er sib­ling brands Rin­voq and Skyrizi.

The new No. 1 this year is Dupix­ent, Sanofi and Re­gen­eron’s treat­ment ap­proved in in­di­ca­tions like asth­ma and eczema, ac­cord­ing to da­ta from re­al­time TV ad track­er iS­pot.tv.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN